Here are Thursday’s biggest analyst calls: Nvidia, Tesla, SpaceX, Meta, CoreWeave, IBM, Block & more
Here are Thursday’s biggest calls on Wall Street: BMO upgrades Block to outperform from market perform BMO said it sees plenty of positive catalysts ahead. “Overall, we believe the balance of growth visibility, margins and tangible product upgrades has leveled-up the Block s tory, and we see multiple expansion driving upside to shares.” Cantor Fitzgerald initiates Celcuity as overweight The firm said the oncology biotech company has plenty more room to run. “We initiate coverage of Celcuity (CELC) with an Overweight rating and a $140/share 12-month price target.” Wolfe initiates Dick’s as outperform Wolfe said it sees EPS upside. “While the industry is challenged, DKS is well positioned as its House of Sport concept ramps, sport agnostic model insulates them from industry pressures, and their increased scale pays dividends.” Bank of America reiterates CoreWeave as buy The firm said it’s sticking with CoreWeave heading into earnings in November. “Into the print, we are focused on four key areas: (1) capacity additions and the pace at which new infrastructure is converted into revenue, (2) upside to operating margins, (3) funding considerations, and (4) the capex outlook. Maintain Buy and $140 PO.” Morgan Stanley reiterates Tesla as equal weight Morgan Stanley raised its price target to $410 per share from $400 following earnings on Wednesday. “We are incrementally more constructive as Tesla’s 3 Q results offer encouraging proof points on Robotaxi scaling and FSD adoption, while improving Auto and Energy fundamentals strengthen the earnings foundation.” Read more. JPMorgan initiates Electra Pharmaceuticals as overweight JPMorgan said the biotech company has “pipeline optionality.” “We are initiating coverage of Electra Therapeutics (ETRA) with an Overweight rating and a December 2027 price target (PT) of $36.” TD Cowen initiates Centerpoint Energy as buy TD Cowen said it sees plenty of room for growth for the utility company. “We are initiating coverage of CNP with a Buy rating and $47 price target.” Baird initiates Kardigan as outperform Baird said the biotech company has a robust pipeline. ” Kardigan is a clinical-stage biotech company specializing in the development of therapies for cardiovascular diseases.” Oppenheimer initiates AeroVironment as outperform Oppenheimer said the drone company is on the “next leg of growth.” “We initiate coverage of AeroVironment (AVAV) with an Outperform rating and a $205 target price.” BMO upgrades Ionis Pharmaceuticals to outperform from market perform BMO said it’s bullish on the company’s triglycerides treatment, Tryngolza. “We upgrade IONS to Outperform and raise our TP to $66 from $54, as the story now centers on Tryngolza with pipeline updates behind us.” Bank of America reiterates SpaceX as buy Bank of America raised its price target to $275 per share from $235. ” SpaceX (SPCX) third quarter results beat the street across metrics and the company raised the ante on what’s coming in 2027.” Goldman Sachs reiterates Nvidia as buy Goldman said Nvidia is firing on all cylinders. “We maintain our Buy rating as we continue to see a positive catalyst path for the stock, including greater visibility into AI datacenter deployments as Nvidia n arrows the supply/demand gap while driving strong capital returns.” HSBC initiates NextEra Energy as buy HSBC said it likes the company’s “growth ambitions.” “We see NextEra as a technology leader, and the use of AI in its own and Dominion’s operations should maintain or even expand operational and cost leadership.” Goldman Sachs reiterates IBM as buy Goldman said the company’s earnings report on Wednesday was “solid.” “We are Buy rated on IBM based our view that the company remains on track to deliver improving software revenue growth and consulting market share gains over time.” Citi reiterates Texas Instruments as a top pick Citi said the company is “best positioned” following earnings on Wednesday. “While we believe the analog market is more than halfway through cyclical recovery TXN r emains best positioned to gain share given its extensive manufacturing capacity.” TD Cowen initiates Talen Energy as buy TD Cowen said the utility company is best positioned. “We are initiating coverage of TLN with a Buy rating and a $475 price target.” Canaccord initiates Ionic Digital as buy Canaccord said the digital infrastructure company has a “nice set of assets.” “As neo-clouds have taken a battering the last few weeks, co-lo and powered shell infrastructure providers have not been spared either. And while cost of capital and GPU useful life continue to be debated, what has not changed is the value of underlying land/power portfolios. And here, we see IOND as an emerging player with a nice set of assets.” Canaccord initiates CleanSpark as buy Canaccord said the company is an “attractive standout.” “Against the backdrop of recent volatility in the broader AI sector CleanSpark is an attractive standout.” Citizens upgrades Omega Healthcare to market outperform from market perform Citizens said it sees a compelling entry point. “We are upgrad ing OHI to Market Outperform and establishing a $52 price target based on 15x 2027E AFFO per share.” Wolfe downgrades Netflix to peer perform from outperform Wolfe said it’s concerned about rising competition. ” NFLX: Downgrade to Peer Perform – Well Explored Problems, Expensive Solutions.” Raymond James upgrades WhiteHorse Financial to outperform from market perform The firm said it sees credit quality getting better. “We are upgrading WHF to Outperform from Market Perform, reflecting improving credit quality and the recently announced strategic review, which we believe could serve as a meaningful catalyst for the stock.” JPMorgan reiterates Meta as overweight JPMorgan raised its price target on Meta to $940 per share from $920 following earnings. “Muse Agent & Enterprise Paths Taking Shape; Reiterate Overweight & $940 PT.” Gordon Haskett upgrades Kohl’s to buy from hold The firm said Kohl’s is compelling and has “value.” “Keeping within our recent desire to recommend retailers with a heightened focus on value (see BJ, DG, and OLLI upgrades over the past two months) . . . we are upgrading Kohl’s to Buy-Rated from Hold-Rated and establishing a $27 Price Target, which implies north of 20% upside.” JPMorgan upgrades CME to overweight from neutral JPMorgan said it sees “immediate near term growth.” “We are upgrading CME t o an Overweight rating and establishing our Dec-2027 price target of $367. We favor market structure / exchange investment ideas and we see CME well-positioned to outperform in the current environment.” Oppenheimer initiates Aevex as outperform Oppenheimer said the autonomous defense tech has plenty of upside. “AEVEX i s one of the most concentrated public plays on affordable autonomous mass. Unmanned systems were about 87% of its 1H26 revenue, and more than 9,300 strike systems have been delivered or committed under Phoenix Ghost and Deep Strike.” UBS reiterates Berkshire Hathaway as buy UBS raised its price target to $942,405 per share from $906,011. “We expect 3Q26 operating earnings to increase modestly y/y despite weaker underwriting results across Berkshire’s Insurance businesses, with the major non- Insurance businesses expected to offset these pressures.” CBRE upgrades MGM to buy from hold CBRE said the share selloff is overdone. “We are upgrading the shares of MGM to Buy and adjusting our PT to $42 (from $50). Our prior Hold rating was based on MGM’s prospective buyout by People Incorporated. However, with People Inc pulling its $48.30 bid and the shares of MGM selling off to near 52-week lows, we see an overreaction in the share price from the Las Vegas Strip headwinds this summer.” Maxim initiates DarkHorse Technologies as buy Maxim said the AI infrastructure company has plenty more room to run. “We expect the transition from Bitcoin (BTC) mining/hosting to AI data center colocation to significantly increase revenue and EBITDA . DRK o perates in the more data center-friendly Tennessee Valley Authority (TVA) region and is focused on improving regional economic growth.”
About the Author
